bitter! Counting the failure of seven major clinical trials in 2016
Release date: 2016-12-28 1. Lilly: Alzheimer's disease drug Solanezumab It is very difficult to find a cure for Alzheimer's disease. It takes a lot of money to develop a “killer†product, and Eli has put a lot of effort and cost into it. In November, Lilly's headquarter
Read more